Dark

Check out our API

BRAXF
BRAXIA SCIENTIFIC CORP
stock OTC

EOD

Jul 31, 2026

0.000001USD0.000%(0.000000)7,000

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 31, 2022

07:31AM EST Support Pharmaceutical and Industry Clinical Trials for Ketamine and Psilocybin Drug Development PR Newswire

Dec 14, 2021

07:01AM EST Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial PR Newswire

Nov 9, 2021

07:02AM EST Braxia Scientific CEO Dr. Roger McIntyre to Join Advisory Board of At-Home PR Newswire

Nov 8, 2021

07:02AM EST Braxia Scientific CEO Dr. Roger McIntyre to Deliver Keynote Address at PR Newswire

Nov 2, 2021

07:31AM EDT Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial PR Newswire

Oct 29, 2021

07:48PM EDT Braxia Scientific Announces Voting Results from the Annual General Meeting of PR Newswire

Oct 27, 2021

07:02AM EDT Braxia Scientific Provides New Audio Webcast and Dial-In Number for Annual PR Newswire

Oct 22, 2021

06:15PM EDT Documentary Series, Providing Access and Promoting Use of Ketamine to Treat Brain-Based Illnesses PR Newswire

Oct 21, 2021

07:01AM EDT Journal of the Royal Society of Medicine Publishes New COVID-19 Suicide PR Newswire

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

Oct 14, 2021

07:02AM EDT Odom and 'Psychedelic Concierge' Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health PR Newswire

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

Oct 4, 2021

04:47PM EDT Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction Benzinga

Sep 30, 2021

02:58PM EDT New Study Suggests Ketamine Could Work Better Without Additional Antidepressants Benzinga

07:34AM EDT Braxia : Ketamine Study Results Show Significant Reduction In Depressive Symptoms And Suicidality RTTNews

07:31AM EDT Significant Reduction in Depressive Symptoms and Suicidality with Ketamine as a Solo Treatment PR Newswire

Aug 30, 2021

06:21PM EDT Braxia Scientific Reports First Quarter 2022 Financial Results; Company PR Newswire

11:21AM EDT Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold Benzinga

Aug 27, 2021

12:52PM EDT Braxia Scientific Launches Broad Criteria Trial On Psilocybin For Depression Benzinga

07:01AM EDT Braxia Scientific to Commence Landmark Clinical Trial to Conduct Canada's First PR Newswire

06:59AM EDT Braxia Scientific Comments on US Class Action PR Newswire

Aug 17, 2021

07:35AM EDT Braxia Scientific Announces Participation at H.C. Wainwright 23rd Annual Global PR Newswire

Aug 6, 2021

07:31AM EDT Braxia Scientific Announces Participation at Canaccord Genuity 2021 Annual PR Newswire

Aug 2, 2021

10:08AM EDT Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected Benzinga

Jul 30, 2021

07:01AM EDT Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter PR Newswire

Jul 28, 2021

05:18PM EDT Braxia Scientific Leadership Receives Funding From Canadian Government To Study Ketamine Therapy Benzinga

07:31AM EDT Government to Study Benefits of Integrating Ketamine with Cognitive Behavioural Therapy to Reduce Suicidality PR Newswire

Jul 26, 2021

08:02AM EDT Psyched: Cybin And Field Trip Head To Wall Street, AOC Pushes For Federal Psychedelics Research, Off-Label Ketamine Covered By Insurance In Canada Benzinga

Jul 22, 2021

09:53AM EDT Canadian Insurance Provider To Cover Off-Label Use Of Ketamine For Treating Depression Benzinga

Jul 20, 2021

07:31AM EDT Braxia Scientific Secures Approval for Direct Billing Insurance on Ketamine PR Newswire

Jul 7, 2021

07:45AM EDT with Oxford University Researchers at AIMday Experimental Medicine in Psychiatry on July 7, 2021 PR Newswire

Jul 6, 2021

07:45AM EDT Braxia Scientific Announces Participation at PSYCH Investor Summit on July 7, PR Newswire

Jul 3, 2021

12:32PM EDT Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies Benzinga

Jun 29, 2021

07:02AM EDT Program to Develop New Generation of Qualified Physicians, Psychotherapists and Psychologists for Mental Health PR Newswire

Jun 21, 2021

10:22AM EDT Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform Benzinga

Jun 17, 2021

05:00PM EDT Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression/ PR Newswire

07:31AM EDT Braxia Scientific Awarded Government of Canada Funding to Complete First of its PR Newswire

Jun 16, 2021

05:00PM EDT and Beyond Virtual Conference Hosted by H.C. Wainwright & Co. on June 17, 2021/ PR Newswire

07:45AM EDT Braxia Scientific to Present at the Psychedelics in Psychiatry and Beyond PR Newswire

Jun 9, 2021

07:05AM EDT American Journal of Psychiatry Publishes International Ketamine and Esketamine PR Newswire

May 31, 2021

07:01AM EDT Braxia Scientific Appoints Dr. David Greenberg to Board of Directors PR Newswire

May 21, 2021

07:06AM EDT /R E P E A T -- Braxia Scientific Announces Symbol Change on OTC markets to PR Newswire

Share